Literature DB >> 23689600

Selective forelimb impairment in rats expressing a pathological TDP-43 25 kDa C-terminal fragment to mimic amyotrophic lateral sclerosis.

Robert D Dayton1, Michael A Gitcho, Elysse A Orchard, Jon D Wilson, David B Wang, Cooper D Cain, Jeffrey A Johnson, Yong-Jie Zhang, Leonard Petrucelli, J Michael Mathis, Ronald L Klein.   

Abstract

Pathological inclusions containing transactive response DNA-binding protein 43 kDa (TDP-43) are common in several neurodegenerative diseases including amyotrophic lateral sclerosis (ALS). TDP-43 normally localizes predominantly to the nucleus, but during disease progression, it mislocalizes to the cytoplasm. We expressed TDP-43 in rats by an adeno-associated virus (AAV9) gene transfer method that transduces neurons throughout the central nervous system (CNS). To mimic the aberrant cytoplasmic TDP-43 found in disease, we expressed a form of TDP-43 with mutations in the nuclear localization signal sequence (TDP-NLS). The TDP-NLS was detected in both the cytoplasm and the nucleus of transduced neurons. Unlike wild-type TDP-43, expression of TDP-NLS did not induce mortality. However, the TDP-NLS induced disease-relevant motor impairments over 24 weeks. We compared the TDP-NLS to a 25 kDa C-terminal proaggregatory fragment of TDP-43 (TDP-25). The clinical phenotype of forelimb impairment was pronounced with the TDP-25 form, supporting a role of this C-terminal fragment in pathogenesis. The results advance previous rodent models by inducing cytoplasmic expression of TDP-43 in the spinal cord, and the non-lethal phenotype enabled long-term study. Approaching a more relevant disease state in an animal model that more closely mimics underlying mechanisms in human disease could unlock our ability to develop therapeutics.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23689600      PMCID: PMC3702099          DOI: 10.1038/mt.2013.88

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   11.454


  38 in total

1.  Inducible long-term gene expression in brain with adeno-associated virus gene transfer.

Authors:  R P Haberman; T J McCown; R J Samulski
Journal:  Gene Ther       Date:  1998-12       Impact factor: 5.250

2.  TDP-43 proteinopathy and motor neuron disease in chronic traumatic encephalopathy.

Authors:  Ann C McKee; Brandon E Gavett; Robert A Stern; Christopher J Nowinski; Robert C Cantu; Neil W Kowall; Daniel P Perl; E Tessa Hedley-Whyte; Bruce Price; Chris Sullivan; Peter Morin; Hyo-Soon Lee; Caroline A Kubilus; Daniel H Daneshvar; Megan Wulff; Andrew E Budson
Journal:  J Neuropathol Exp Neurol       Date:  2010-09       Impact factor: 3.685

3.  Expansive gene transfer in the rat CNS rapidly produces amyotrophic lateral sclerosis relevant sequelae when TDP-43 is overexpressed.

Authors:  David B Wang; Robert D Dayton; Phillip P Henning; Cooper D Cain; Li Ru Zhao; Lisa M Schrott; Elysse A Orchard; David S Knight; Ronald L Klein
Journal:  Mol Ther       Date:  2010-09-28       Impact factor: 11.454

Review 4.  The advent of AAV9 expands applications for brain and spinal cord gene delivery.

Authors:  Robert D Dayton; David B Wang; Ronald L Klein
Journal:  Expert Opin Biol Ther       Date:  2012-04-20       Impact factor: 4.388

5.  TDP-43 transgenic mice develop spastic paralysis and neuronal inclusions characteristic of ALS and frontotemporal lobar degeneration.

Authors:  Hans Wils; Gernot Kleinberger; Jonathan Janssens; Sandra Pereson; Geert Joris; Ivy Cuijt; Veerle Smits; Chantal Ceuterick-de Groote; Christine Van Broeckhoven; Samir Kumar-Singh
Journal:  Proc Natl Acad Sci U S A       Date:  2010-02-03       Impact factor: 11.205

6.  Cytoplasmic mislocalization of TDP-43 is toxic to neurons and enhanced by a mutation associated with familial amyotrophic lateral sclerosis.

Authors:  Sami J Barmada; Gaia Skibinski; Erica Korb; Elizabeth J Rao; Jane Y Wu; Steven Finkbeiner
Journal:  J Neurosci       Date:  2010-01-13       Impact factor: 6.167

7.  Dose and promoter effects of adeno-associated viral vector for green fluorescent protein expression in the rat brain.

Authors:  Ronald L Klein; Mary E Hamby; Yan Gong; Aaron C Hirko; Samuel Wang; Jeffrey A Hughes; Michael A King; Edwin M Meyer
Journal:  Exp Neurol       Date:  2002-07       Impact factor: 5.330

8.  Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations.

Authors:  Ian R A Mackenzie; Eileen H Bigio; Paul G Ince; Felix Geser; Manuela Neumann; Nigel J Cairns; Linda K Kwong; Mark S Forman; John Ravits; Heather Stewart; Andrew Eisen; Leo McClusky; Hans A Kretzschmar; Camelia M Monoranu; J Robin Highley; Janine Kirby; Teepu Siddique; Pamela J Shaw; Virginia M-Y Lee; John Q Trojanowski
Journal:  Ann Neurol       Date:  2007-05       Impact factor: 10.422

9.  TDP-43 immunoreactivity in hippocampal sclerosis and Alzheimer's disease.

Authors:  Catalina Amador-Ortiz; Wen-Lang Lin; Zeshan Ahmed; David Personett; Peter Davies; Ranjan Duara; Neill R Graff-Radford; Michael L Hutton; Dennis W Dickson
Journal:  Ann Neurol       Date:  2007-05       Impact factor: 10.422

10.  Dysregulation of the ALS-associated gene TDP-43 leads to neuronal death and degeneration in mice.

Authors:  Lionel M Igaz; Linda K Kwong; Edward B Lee; Alice Chen-Plotkin; Eric Swanson; Travis Unger; Joe Malunda; Yan Xu; Matthew J Winton; John Q Trojanowski; Virginia M-Y Lee
Journal:  J Clin Invest       Date:  2011-01-04       Impact factor: 14.808

View more
  20 in total

1.  Reversible behavioral phenotypes in a conditional mouse model of TDP-43 proteinopathies.

Authors:  Julio A Alfieri; Natalia S Pino; Lionel M Igaz
Journal:  J Neurosci       Date:  2014-11-12       Impact factor: 6.167

2.  Initial gene vector dosing for studying symptomatology of amyotrophic lateral sclerosis in non-human primates.

Authors:  Kasey L Jackson; Robert D Dayton; Jeanne M Fisher-Perkins; Peter J Didier; Kate C Baker; Maria Weimer; Amparo Gutierrez; Cooper D Cain; J Michael Mathis; Michael A Gitcho; Bruce A Bunnell; Ronald L Klein
Journal:  J Med Primatol       Date:  2015-01-29       Impact factor: 0.667

3.  An insoluble frontotemporal lobar degeneration-associated TDP-43 C-terminal fragment causes neurodegeneration and hippocampus pathology in transgenic mice.

Authors:  Adam K Walker; Kalyan Tripathy; Clark R Restrepo; Guanghui Ge; Yan Xu; Linda K Kwong; John Q Trojanowski; Virginia M-Y Lee
Journal:  Hum Mol Genet       Date:  2015-10-16       Impact factor: 6.150

Review 4.  The extreme N-terminus of TDP-43 mediates the cytoplasmic aggregation of TDP-43 and associated toxicity in vivo.

Authors:  Hiroki Sasaguri; Jeannie Chew; Ya-Fei Xu; Tania F Gendron; Aliesha Garrett; Chris W Lee; Karen Jansen-West; Peter O Bauer; Emilie A Perkerson; Jimei Tong; Caroline Stetler; Yong-Jie Zhang
Journal:  Brain Res       Date:  2016-05-04       Impact factor: 3.252

5.  Methods and Tips for Intravenous Administration of Adeno-associated Virus to Rats and Evaluation of Central Nervous System Transduction.

Authors:  Mychal S Grames; Kasey L Jackson; Robert D Dayton; John A Stanford; Ronald L Klein
Journal:  J Vis Exp       Date:  2017-08-25       Impact factor: 1.355

6.  Preservation of forelimb function by UPF1 gene therapy in a rat model of TDP-43-induced motor paralysis.

Authors:  K L Jackson; R D Dayton; E A Orchard; S Ju; D Ringe; G A Petsko; L E Maquat; R L Klein
Journal:  Gene Ther       Date:  2014-11-06       Impact factor: 5.250

Review 7.  TDP43 and RNA instability in amyotrophic lateral sclerosis.

Authors:  Kaitlin Weskamp; Sami J Barmada
Journal:  Brain Res       Date:  2018-01-31       Impact factor: 3.252

8.  Shortened TDP43 isoforms upregulated by neuronal hyperactivity drive TDP43 pathology in ALS.

Authors:  Kaitlin Weskamp; Elizabeth M Tank; Roberto Miguez; Jonathon P McBride; Nicolás B Gómez; Matthew White; Ziqiang Lin; Carmen Moreno Gonzalez; Andrea Serio; Jemeen Sreedharan; Sami J Barmada
Journal:  J Clin Invest       Date:  2020-03-02       Impact factor: 14.808

Review 9.  Rodent Models of Amyotrophic Lateral Sclerosis.

Authors:  Thomas Philips; Jeffrey D Rothstein
Journal:  Curr Protoc Pharmacol       Date:  2015-06-01

Review 10.  Molecular, functional, and pathological aspects of TDP-43 fragmentation.

Authors:  Deepak Chhangani; Alfonso Martín-Peña; Diego E Rincon-Limas
Journal:  iScience       Date:  2021-04-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.